The AIWO 181 Blood Test: What 181 Markers Reveal About Your Health?
Most Blood Tests Tell You If You're Sick. This One Tells You Something Far More Valuable.
The standard health check-up has barely changed in decades.
A basic lipid panel. A fasting glucose. A CBC. If nothing is flagged, you leave with a clean bill of health and a vague sense of reassurance until the next check-up, or until something goes wrong.
But here's the uncomfortable truth about conventional diagnostics: they are designed to detect disease, not prevent it. They catch problems late often after years of silent progression, when intervention is harder, more expensive, and less effective.
The AIWO 181 Blood Test was built on an entirely different philosophy. Not to identify what has already broken down, but to reveal what is quietly shifting before it does.
181 biomarkers. One comprehensive picture. A data-driven foundation for living longer, healthier, and younger.
Why 181 Markers? Why Not Just the Standard 30?
A typical full-body health check in India covers somewhere between 25 and 60 parameters. These panels are adequate for emergency medicine. They are not adequate for longevity medicine.
The human body is an interconnected system. Cardiovascular health cannot be assessed in isolation from metabolic function. Hormonal balance cannot be interpreted without knowing the inflammatory status. Energy and cognitive performance are downstream of a dozen overlapping biochemical variables that a standard CBC simply does not capture.
The AIWO 181 panel is designed to map these interdependencies with precision. It draws from the same biomarker science used in advanced preventive medicine and longevity research, the kind practiced at institutions that think about healthspan, not just disease management.
Every single one of the 181 markers was selected because it carries clinical or longevity-relevant signal. Nothing is included as filler. Everything has interpretive value.
The 10 Key Systems the AIWO 181 Panel Assesses
1. Complete Blood Count and Haematological Health
At the foundation of any comprehensive diagnostic panel is the complete blood count, including red blood cells, white blood cells, haemoglobin, haematocrit, platelet count, and differential counts across lymphocytes, neutrophils, monocytes, eosinophils, and basophils.
This is not just anemia screening. The differential white blood cell count, for instance, provides a window into immune activation, allergic responses, and chronic infection status. The neutrophil-to-lymphocyte ratio, a marker emerging in longevity research correlates with systemic inflammation and biological ageing rate.
2. Metabolic Health and Blood Sugar Regulation
Metabolic dysfunction is the upstream driver of an extraordinary range of chronic diseases from cardiovascular disease to neurodegeneration. Yet most standard tests only measure fasting glucose, missing the full picture entirely.
The AIWO 181 panel examines fasting glucose alongside HbA1c (three-month average blood sugar), fasting insulin, and HOMA-IR, a calculated index of insulin resistance. Together, these four markers reveal far more than any single reading can.
Someone can have a perfectly normal fasting glucose reading while running dangerously high fasting insulin, a state of compensated insulin resistance that is quietly accelerating cellular aging and cardiovascular risk. The AIWO 181 panel catches this. A standard check-up does not.
3. Cardiovascular Risk Beyond Total Cholesterol
The conventional lipid panel total cholesterol, HDL, LDL, and triglycerides, has been the gold standard in cardiovascular risk assessment for decades. It is no longer sufficient.
Research has consistently demonstrated that total LDL cholesterol is a crude predictor of cardiovascular events. What matters far more is the type, size, and behaviour of lipid particles circulating in the bloodstream.
The AIWO 181 panel extends cardiovascular assessment to include ApoB (apolipoprotein B) a direct count of atherogenic lipoprotein particles, widely considered a superior marker to LDL for predicting arterial disease. It includes Lp(a) lipoprotein(a) a genetically determined cardiovascular risk factor that is independent of lifestyle and invisible to a standard lipid panel. Homocysteine, a potent independent risk marker for arterial damage and thrombosis, is also captured.
These are the markers that cardiovascular longevity researchers track. They are conspicuously absent from most routine health checks.
4. Liver Function and Detoxification Capacity
The liver performs over 500 functions from detoxification and protein synthesis to fat metabolism and hormone clearance. Its health is foundational to the health of every other system.
A full liver function panel in the AIWO 181 includes ALT, AST, ALP, GGT, bilirubin (total and direct), total protein, albumin, and globulin. GGT, in particular, deserves attention beyond its role in liver health; elevated GGT is a sensitive marker of oxidative stress and a robust predictor of metabolic and cardiovascular risk, even within the so-called normal range.
5. Kidney Function and Electrolyte Balance
The kidneys filter approximately 200 litres of blood daily, regulate blood pressure, manage fluid and electrolyte balance, and activate vitamin D. Silent kidney stress subclinical in the early stages, often shows no symptoms until significant function has been lost.
The AIWO 181 panel covers creatinine, blood urea nitrogen (BUN), uric acid, eGFR (estimated glomerular filtration rate), and a full electrolyte panel including sodium, potassium, chloride, calcium, phosphorus, and bicarbonate.
Uric acid, in particular, is frequently underappreciated outside the context of gout. Elevated uric acid correlates independently with cardiovascular risk, metabolic syndrome, and systemic inflammation.
6. Thyroid Health All Four Axes
Standard thyroid screening tests TSH (thyroid-stimulating hormone). That is often the beginning and end of thyroid assessment in routine care.
TSH alone is an incomplete picture.
The AIWO 181 panel tests TSH, Free T3, Free T4, and thyroid antibodies (anti-TPO and anti-thyroglobulin). This matters because subclinical hypothyroidism where TSH is mildly elevated but within broadly defined normal ranges, can present with fatigue, cognitive sluggishness, weight resistance, and mood disruption for years before TSH crosses the threshold that triggers a clinical diagnosis. Thyroid antibodies reveal autoimmune thyroid activity (Hashimoto's) that can exist long before TSH shifts.
Comprehensive thyroid assessment is the difference between telling someone their thyroid is "normal" and actually understanding what their thyroid is doing.
7. Hormonal Health: The Master Regulators
Hormones coordinate virtually every system in the body. Their balance or imbalance shapes energy, body composition, sexual function, cognitive performance, bone density, mood, and the rate at which the body ages at a cellular level.
The AIWO 181 panel assesses the full hormonal landscape:
Sex Hormones: Total testosterone, free testosterone, DHEA-S, oestradiol, progesterone, FSH, LH, SHBG (sex hormone-binding globulin). For men, this reveals the full picture of androgen status, not just whether testosterone is "in range" but whether it is bioavailable and in proportion with oestradiol and SHBG. For women, this maps hormonal rhythms, fertility status, and perimenopausal transition with precision.
Adrenal Hormones: Cortisol, the body's primary stress hormone, can suppress immune function, drive abdominal fat accumulation, disrupt sleep architecture, and accelerate biological ageing when chronically elevated. DHEA-S, produced by the adrenal glands, acts as a counter-regulatory longevity hormone that tends to decline with age.
Metabolic Hormones: Fasting insulin and its relationship with glucose markers inform the body's ability to manage energy efficiently, a central pillar of metabolic longevity.
8. Inflammation Markers The Silent Ageing Signal
Chronic low-grade inflammation, sometimes called "inflammaging" in longevity research, is now considered one of the primary biological mechanisms driving accelerated ageing and chronic disease.
The challenge is that systemic inflammation is largely silent. It produces no pain, no obvious symptoms, only a quiet, sustained biochemical disruption that accumulates damage over years.
The AIWO 181 panel captures multiple layers of inflammatory status:
hsCRP (high-sensitivity C-reactive protein) is the most widely validated blood marker of cardiovascular and general inflammatory risk. Unlike standard CRP, the high-sensitivity version detects low levels of inflammation that exist well below the threshold of acute illness, exactly the kind of chronic background inflammation that drives long-term damage.
ESR (erythrocyte sedimentation rate) and ferritin provide additional inflammatory signals, while fibrinogen, a clotting protein that rises with inflammation, adds a cardiovascular risk dimension.
IL-6 (interleukin-6), a key inflammatory cytokine involved in immune signalling, is included in comprehensive AIWO 181 assessments. Elevated IL-6 is consistently associated with accelerated biological ageing and reduced longevity in population studies.
9. Nutritional Deficiencies What You're Missing
India has some of the highest rates of micronutrient deficiency in the world. Vitamin D deficiency affects an estimated 70–80% of the urban Indian population. B12 deficiency is rampant, particularly in populations with low or no animal product consumption. Iron deficiency is one of the most common nutritional conditions across all demographics.
The AIWO 181 panel runs a comprehensive micronutrient assessment of Vitamin D (25-OH), Vitamin B12, folate, serum iron, TIBC, transferrin saturation, ferritin, zinc, magnesium, calcium, phosphorus, and Vitamin B1 (thiamine), among others.
These are not minor parameters. Vitamin D insufficiency impairs immune function, hormonal regulation, bone metabolism, and mood. Low magnesium almost universally undertested affects over 300 enzymatic processes and is deeply intertwined with sleep quality, glucose metabolism, and cardiovascular health.
Most people supplementing Vitamin D or B12 have never actually confirmed their deficiency through testing. Most are guessing. The AIWO 181 panel removes the guesswork.
10. Longevity-Specific and Emerging Biomarkers
Beyond conventional clinical chemistry, the AIWO 181 panel incorporates markers that sit at the frontier of longevity medicine.
Omega-3 Index the percentage of EPA and DHA in red blood cell membranes is among the most predictive cardiovascular longevity markers, associated in population studies with reduced cardiovascular mortality, improved cognitive ageing, and lower systemic inflammation.
Insulin-like Growth Factor 1 (IGF-1) is a key mediator of cellular growth and repair, tightly linked to GH (growth hormone) secretion. Both low and very high IGF-1 carry health implications. Optimal IGF-1 within the longevity-appropriate range supports lean muscle mass, bone health, and cellular regeneration.
GGT (gamma-glutamyl transferase) functions both as a liver marker and as one of the most sensitive blood-based indicators of oxidative stress, the cumulative free radical damage that drives biological ageing.
How to Read the AIWO 181 Report: Beyond "Normal" and "Abnormal"
One of the most significant limitations of standard blood test interpretation is the binary nature of reference ranges: either you're "normal" or you're not.
Reference ranges are typically built from population averages, not from optimal health. A result that falls within the standard reference range may still indicate suboptimal function when viewed through a longevity lens. For example, a TSH of 3.5 mIU/L is technically within the normal range in most laboratories. But longevity-focused practitioners often prefer to see TSH in the lower half of the range for optimal thyroid function.
The AIWO 181 diagnostic report is designed to go beyond binary classification. It contextualises results against longevity-optimised reference ranges, flags interdependencies between markers, and produces an actionable profile, not just a list of numbers.
The goal is not to tell you whether you are sick or not sick. The goal is to map precisely where your biology is optimised, where it is suboptimal, and what intervention nutritional, lifestyle, or supplementation is most likely to move the needle.
Who Should Take the AIWO 181 Blood Test?
The short answer: anyone who wants to understand their health with precision rather than assumption.
The Proactive Professional: High-performing individuals aged 30–55 who feel functional but want to know what their biology is actually doing beneath the surface before symptoms appear.
The Fitness Optimiser: Someone who trains consistently, eats well, and supplements thoughtfully but wants data-driven confirmation that their efforts are translating into measurable physiological benefit.
The Longevity Seeker: Anyone actively interested in slowing biological ageing, extending healthspan, and making evidence-based decisions about their longevity protocol.
The Wellness Parent: Adults who have noticed declining energy, unexplained weight changes, cognitive sluggishness, disrupted sleep, or hormonal shifts and want answers, not reassurances.
If you have been managing your health on assumptions, the AIWO 181 panel replaces assumptions with evidence.
The AIWO 181 and the LONGEVIS MATRIX: Data That Drives Action
A blood test is only as valuable as the action it enables.
The AIWO 181 diagnostic panel is built as the data foundation for AIWO's LONGEVIS MATRIX the 11-pillar longevity framework that guides personalised supplementation, nutrition, and lifestyle protocols. Each pillar of the matrix from metabolic health and inflammation management to hormonal optimisation and mitochondrial function maps directly to specific clusters of the 181 markers.
This means the AIWO 181 result is not the end of the diagnostic process. It is the beginning of a precision protocol. It tells you exactly which pillars of your longevity architecture need support, so that supplementation and lifestyle adjustments are targeted, not generic.
Final Thought: You Cannot Optimise What You Have Not Measured
The most important insight in modern preventive medicine is disarmingly simple.
Most people manage their health the way they once managed their finances without looking at the numbers, trusting that if something were seriously wrong, they would feel it. But biology does not send polite advance notices. The conditions that kill most people cardiovascular disease, type 2 diabetes, cancer, neurodegeneration spend years accumulating silently before they become impossible to ignore.
The AIWO 181 Blood Test is built for people who are not willing to wait.
181 markers. Complete visibility. A science-backed roadmap for the health decisions that will shape the next decade of your life.
Because the most powerful thing you can do for your future health is understand your current biology in full.
Share